Skip to main content
HR 5853 112th Congress House

Gray Market Drug Reform and Transparency Act of 2012

Introduced: May 22, 2012 See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 25, 2012
Referred to the Subcommittee on Health.
May 22, 2012
Referred to the House Committee on Energy and Commerce.
May 22, 2012
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 25, 2012

Referred to the Subcommittee on Health.

Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5853: Gray Market Drug Reform and Transparency Act of 2012. 112th Congress. Open America. https://openamerica.io/bill/112-HR-5853/
MLA
"H.R. 5853: Gray Market Drug Reform and Transparency Act of 2012." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-HR-5853/.
Bluebook (legal)
H.R. 5853, 112th Cong. (2026), https://openamerica.io/bill/112-HR-5853/.
Markdown link
[H.R. 5853: Gray Market Drug Reform and Transparency Act of 2012](https://openamerica.io/bill/112-HR-5853/)
Report a problem